BioPharmX Corp to Merge with Timber Pharmaceuticals

LEO Pharma Acquires Timber Pharmaceuticals (TMB-001) in Up to $36 Million Deal

August 21, 2023

Healthcare Services

LEO Pharma signed an agreement to acquire U.S.-listed Timber Pharmaceuticals in a deal valued at up to $36 million. The transaction will add Timber’s late-stage dermatology asset, TMB-001 (topical reformulation of isotretinoin for congenital ichthyosis), to LEO Pharma’s pipeline; closing is expected in Q4 2023, subject to shareholder approval and other conditions.

MJH Life Sciences Acquires Pharmaceutical Commerce

July 9, 2020

Media & Entertainment

MJH Life Sciences has acquired Pharmaceutical Commerce, a multimedia B2B publication formerly published by Healthcare Commerce Media Corporation. The acquisition expands MJH’s healthcare media portfolio and strengthens its reach into the biopharma commercial operations and supply-chain audience, adding a magazine with a controlled circulation of roughly 21,000 and multiple newsletters and events.

Shionogi Inc. Acquires Qpex Biopharma, Inc.

June 26, 2023

Pharmaceuticals

Shionogi Inc., the U.S. subsidiary of Shionogi & Co., Ltd., entered into a definitive agreement to acquire San Diego-based clinical-stage antimicrobial developer Qpex Biopharma, Inc. The acquisition (upfront $100 million plus up to $40 million in milestones) brings Qpex's investigational beta-lactamase inhibitor xeruborbactam and expands Shionogi's infectious disease R&D capabilities and pipeline.

MedPharm and Tergus Pharma Merge to Create Topical & Transdermal CDMO Leader

July 8, 2024

Pharmaceuticals

MedPharm and Tergus Pharma have merged and will operate under the MedPharm name to create an integrated, end-to-end topical and transdermal CDMO. Ampersand Capital Partners and Bourne Partners Strategic Capital assume majority ownership of the combined company while Great Point Partners retains a significant minority stake; Michael Kane is appointed CEO and Patrick Walsh remains Executive Chairman.

Groupe Berkem Acquires i.Bioceuticals from International Nutrition Company (INC)

February 16, 2023

Food & Beverage

Groupe Berkem has acquired i.Bioceuticals, the exclusive North American distributor of OPC and pine bark extracts from Dutch supplier International Nutrition Company (INC). The cash transaction transfers i.Bioceuticals' Massachusetts-based team to Groupe Berkem as the Group expands its bio-based health, beauty and nutraceutical offering and strengthens its footprint in North America.

CorMedix Acquires Melinta Therapeutics for $300 Million

August 7, 2025

Biotechnology

CorMedix Inc. has entered into a definitive agreement to acquire Melinta Therapeutics, paying $300 million upfront (including $260 million cash and $40 million in CorMedix equity to Melinta shareholders), plus up to $25 million in a regulatory milestone and tiered royalties. The deal is expected to close in September, subject to customary closing conditions and U.S. regulatory approval.